APA

Feliu J., Borrega P., León A., López-Gómez L., López M., Castro J., Belda-Iniesta C., Barriuso J., Martínez V. & González-Barón M. (20110131). Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer. : Cancer chemotherapy and pharmacology.

Chicago

Feliu J, Borrega P, León A, López-Gómez L, López M, Castro J, Belda-Iniesta C, Barriuso J, Martínez V and González-Barón M. 20110131. Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer. : Cancer chemotherapy and pharmacology.

Harvard

Feliu J., Borrega P., León A., López-Gómez L., López M., Castro J., Belda-Iniesta C., Barriuso J., Martínez V. and González-Barón M. (20110131). Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer. : Cancer chemotherapy and pharmacology.

MLA

Feliu J, Borrega P, León A, López-Gómez L, López M, Castro J, Belda-Iniesta C, Barriuso J, Martínez V and González-Barón M. Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer. : Cancer chemotherapy and pharmacology. 20110131.